Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Since the 1990s, the cancer mortality rate in the U.S. has steadily declined. Yet liver cancer death rates in...
During late March and early April, the U.S. Food and Drug Administration (FDA) made several decisions that have increased...
The Fifth AACR New Horizons in Cancer Research (NHiCR) international conference has concluded, and the more than 400 attendees...
Shenzhen is a remarkable place. It serves as a gateway to Hong Kong, and in its short 40-year history...
Greetings from Shenzhen, China, where the Fifth AACR New Horizons in Cancer Research (NHiCR) Conference is now underway. The event’s...
As a regular feature on this blog, we spotlight 10 “must read” articles selected by our editors from each...
The American Association for Cancer Research (AACR) Annual Meeting 2019 drew more than 21,000 attendees, providing a robust forum...
Therapeutics that target two proteins called cyclin-dependent kinase 4 (CDK4) and CDK6 have revolutionized treatment for breast cancer, Richard...
One of the world’s largest cancer research conferences, the AACR Annual Meeting 2019, came to an end with a...
Over the course of AACR Annual Meeting 2019, there were 213 presentations on incredibly exciting clinical trials. This is...